(2005). Arylamine N-acetyltransferases: what we learn from genes and genomes.
(2007). Arylamine N-acetyltransferases.
(2003). Arylamine Nacetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function.
(2005). Ascertainment bias in studies of human genome-wide polymorphism.
(2006). Balancing selecton and its effects on sequences in nearby genome regions.
(2003). Clinal patterns of human Y chromosomal diversity in continental Italy and Greece are dominated by drift and founder effects.
(1999). Combined use of biallelic and microsatellite Y-chromosome polymorphisms to infer affinities among African populations.
(2006). Comment on ‘‘Ongoing adaptive evolution of ASPM, a brain size determinant in Homo sapiens’’ and ‘‘Microcephalin, a gene regulating brain size, continues to evolve adaptively in humans’’. Science 313: 172; author reply 172.
(2003). Correcting for ascertainment biases when analyzing SNP data: applications to the estimation of linkage disequilibrium.
(2006). Deciphering the ancient and complex evolutionary history of human arylamine Nacetyltransferase genes.
(2002). Detecting recent positive selection in the human genome from haplotype structure.
(2007). Diet and the evolution of human amylase gene copy number variation.
(2003). DnaSP, DNA polymorphism analyses by the coalescent and other methods.
(2005). Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening.
(2006). Folate and human reproduction.
(2007). Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2.
(2006). Gene nutrient interactions and evolution.
(2002). Generating samples under a Wright-Fisher neutral model of genetic variation.
(2004). Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.
(2006). Genomic insights into positive selection.
(2006). Global landscape of recent inferred Darwinian selection for Homo sapiens.
(2002). Globalization, diets and noncommunicable diseases.
(2001). Haplotype variation and linkage disequilibrium in 313 human genes.
(2003). Linkage disequilibrium and inference of ancestral recombination in 538 singlenucleotide polymorphism clusters across the human genome.
(2006). Loss of function polymorphisms in NAT1 protect against spina bifida.
(2004). Maximum-likelihood estimation of demographic parameters using the frequency spectrum of unlinked single-nucleotide polymorphisms.
(2002). Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis. Mutat Res 506–507: 65–
(1985). N-acetylation pharmacogenetics.
(2006). N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.
(2000). NAcetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women.
(2005). Natural selection on protein-coding genes in the human genome.
(1988). Peoples of the World. Moscow: Soviet Encyclopedy Publ.
(2004). Population genetic analysis of ascertained SNP data.
(2001). Population genetic structure of variable drug response.
(2005). Population genetics of CAPN10 and GPR35: implications for the evolution of type 2 diabetes variants.
(2004). Population history and natural selection shape patterns of genetic variation in 132 genes.
(2006). Positive natural selection in the human lineage.
(2001). Recombination, balancing selection and phylogenies
(2004). Reconstituting the frequency spectrum of ascertained single-nucleotide polymorphism data.
(2006). Reconstructing human origins in the genomic era.
(2002). Report of a joint FAO/WHO expert consultation.
(1999). Rohl A
(2006). Scan of human genome reveals no new loci under ancient balancing selection.
(2003). Signatures of natural selection in the human genome.
(2006). Soft sweeps III: the signature of positive selection from recurrent mutation.
(1989). Statistical method for testing the neutral mutation hypothesis by DNA polymorphism.
(2006). Sub-Saharan African coding sequence variation and haplotype diversity at the NAT2 gene.
(1987). The acetylator genes and drug response.
(2001). The discovery of singlenucleotide polymorphisms and inferences about human demographic history.
(2004). The fine-scale structure of recombination rate variation in the human genome.
(2001). The neutral theory in the genomic era.
(2005). The signature of positive selection on standing genetic variation.
(2007). transcription start sites and quantitation of NAT2-specific mRNA in human tissues.
(1984). Transition from a hunter-gatherer to a settled lifestyle in the !Kung San: effect on iron, folate, and vitamin B12 nutrition.
(2007). Ychromosomal variation in the Czech Republic.